Tempus AI, Inc.'s unique data assets and AI-driven oncology solutions make it a promising buy. Click to read more on why the ...

Today, Zacks Investment Ideas feature highlights Palantir PLTR, Tempus AI TEM and Comfort Systems USA FIX. These 3 AI-Relate ...

Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2025 investor letter. A copy ...

Tempus AI, Inc. is revolutionizing healthcare genomics with AI and data partnerships. Click here to read an analysis on TEM ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

A technology company specializing in the application of artificial intelligence to advance precision medicine and patient ...

In its first-quarter 2025 investor letter, Baron Discovery Fund highlighted stocks such as Tempus AI, Inc. (NASDAQ:TEM) . Tempus AI, Inc. (NASDAQ:TEM) is a healthcare technology company.

The stakes of Hinge Health's investors and executives are now worth millions after the company debuted on the stock market.

In a report released today, David Westenberg from Piper Sandler maintained a Hold rating on Tempus AI, Inc. Class A (TEM – Research Report), with a price target of $70.00. The c ...

From surgical precision tools to real-time diagnostics, brain-responsive stimulation, and multi-disease detection systems, AI ...

Brainomix, a global leader in AI-powered imaging solutions in stroke and lung fibrosis, today announced the appointment of ...